| scholarly article | Q13442814 |
| P50 | author | Helen Atherton | Q28323673 |
| Jørgen Skov Jensen | Q37376597 | ||
| Pippa Oakeshott | Q88999151 | ||
| Adamma Aghaizu | Q89167241 | ||
| P2093 | author name string | Fiona Reid | |
| David Taylor-Robinson | |||
| Ian Simms | |||
| Phillip Hay | |||
| Sally Kerry | |||
| Birthe Dohn | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycoplasma genitalium | Q1930909 |
| P304 | page(s) | 1160-1166 | |
| P577 | publication date | 2010-10-13 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study | |
| P478 | volume | 51 |
| Q55291001 | 'Test n Treat (TnT)'- Rapid testing and same-day, on-site treatment to reduce rates of chlamydia in sexually active further education college students: study protocol for a cluster randomised feasibility trial. |
| Q55260830 | 'Test n Treat (TnT)': a cluster-randomised feasibility trial of frequent, rapid-testing and same-day, on-site treatment to reduce rates of chlamydia in high-risk further education college students: statistical analysis plan. |
| Q38922868 | 2016 European guideline on Mycoplasma genitalium infections |
| Q37572093 | A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London |
| Q47552294 | A silent epidemic: the prevalence, incidence and persistence of Mycoplasma genitalium among young, asymptomatic high-risk women in the United States |
| Q35934198 | Apparently-Different Clearance Rates from Cohort Studies of Mycoplasma genitalium Are Consistent after Accounting for Incidence of Infection, Recurrent Infection, and Study Design |
| Q40215194 | Association of Recent Bacterial Vaginosis With Acquisition of Mycoplasma genitalium |
| Q38949023 | Background review for the 2016 European guideline on Mycoplasma genitalium infections |
| Q37382490 | Bacterial Load in Daily Urine Samples of Patients Infected with Mycoplasma genitalium, Mutation Analysis, and Response to Treatment |
| Q89612603 | Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia |
| Q37849099 | Chlamydia trachomatis, Mycoplasma genitalium and Ureaplasma urealyticum among students in northern Norway |
| Q36401083 | Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) |
| Q37611991 | Experimental Infection of Pig-Tailed Macaques (Macaca nemestrina) with Mycoplasma genitalium |
| Q34431657 | Frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women: a community based cohort study |
| Q36055770 | Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study |
| Q33797838 | In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains |
| Q57035503 | Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis |
| Q26796722 | Management of Mycoplasma genitalium infections - can we hit a moving target? |
| Q58753889 | Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary medicine clinic attendees |
| Q93104673 | Molecular Testing for Mycoplasma genitalium in the United States: Results from the AMES Prospective Multicenter Clinical Study |
| Q37172382 | Molecular epidemiology of selected sexually transmitted infections |
| Q40271087 | Multidrug-resistant Mycoplasma genitalium infections in Europe |
| Q42650263 | Mycoplasma genitalium Infection in Adults Reporting Sexual Contact with Infected Partners, Australia, 2008-2016. |
| Q40071927 | Mycoplasma genitalium Infection in Men. |
| Q90660138 | Mycoplasma genitalium detection in urogenital specimens from symptomatic and asymptomatic men and women using the cobas TV/MG test |
| Q38609855 | Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen |
| Q40084684 | Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women |
| Q63752782 | Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis |
| Q28083641 | Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis |
| Q42355223 | Mycoplasma genitalium infections: current treatment options and resistance issues |
| Q35008363 | Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey |
| Q90111635 | Mycoplasma genitalium, a stealth female reproductive tract |
| Q26747053 | Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women? |
| Q34403627 | Mycoplasma genitalium: a review |
| Q35659940 | Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease |
| Q35090137 | Mycoplasma genitalium: from Chrysalis to multicolored butterfly |
| Q35542157 | Mycoplasma genitalium: should we treat and how? |
| Q40822524 | Mycoplasma hominis and Gardnerella vaginalis display a significant synergistic relationship in bacterial vaginosis |
| Q37811069 | Mycoplasmas in pregnancy |
| Q37592110 | Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda |
| Q37845477 | Pelvic inflammatory disease: identifying research gaps--proceedings of a workshop sponsored by Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases, November 3-4, 2011. |
| Q36931777 | Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections |
| Q40062218 | Prevalence and significance of Mycoplasma genitalium in women living with HIV in Denmark |
| Q89209016 | Prevalence of Chlamydia trachomatis in Pregnant Iranian Women: A Systematic Review and Meta-Analysis |
| Q50026302 | Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis |
| Q90683421 | Prevalence of Mycoplasma genitalium infection in women with bacterial vaginosis |
| Q34269050 | Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium |
| Q37638819 | Research benefits of storing genitourinary samples: 16S rRNA sequencing to evaluate vaginal bacterial communities |
| Q52644139 | Risk factors for Mycoplasma genitalium endometritis and incident infection: a secondary data analysis of the T cell Response Against Chlamydia (TRAC) Study. |
| Q30239986 | Sexually transmitted diseases and infertility. |
| Q34479272 | Sexually transmitted diseases treatment guidelines, 2015. |
| Q47140897 | Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model |
| Q38560388 | The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis |
| Q40080903 | The Unique Microbiology and Molecular Pathogenesis of Mycoplasma genitalium |
| Q35836824 | The effect of medical male circumcision on urogenital Mycoplasma genitalium among men in Kisumu, Kenya |
| Q34261217 | The evolution of Mycoplasma genitalium. |
| Q35100207 | The prevalence of urethral and rectal Mycoplasma genitalium among men who have sex with men in China, a cross-sectional study |
| Q49427935 | The prevalence of, and risk factors for, mycoplasma genitalium infection among infertile women in Ibadan: A cross-sectional study |
| Q41046965 | Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women |
| Q34375770 | Timing of progression from Chlamydia trachomatis infection to pelvic inflammatory disease: a mathematical modelling study |
| Q35052845 | Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin |
| Q21133562 | Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic |
| Q36577240 | Which sexually active young female students are most at risk of pelvic inflammatory disease? A prospective study. |
| Q89530439 | [Recurrent Urogynecological Infections] |
Search more.